Pharmaceutical News

RSS

FDA accepts DURECT's New Drug Application for POSIDUR

DURECT Corporation today announced that the New Drug Application for the investigational product POSIDUR (SABER-Bupivacaine) has been accepted by the U.S. Food and Drug Administration indicating that the application is sufficiently complete to permit a substantive review.

20 Jun 2013

Report: Improper prescription drug use drives up cost of care

Doctors and hospitals could save the U.S. $213 billion annually if they used prescription drugs more wisely, according to IMS health.

20 Jun 2013

New study shows that dietary fructose causes liver damage even without weight gain

The role of dietary fructose in the development of obesity and fatty liver diseases remains controversial, with previous studies indicating that the problems resulted from fructose and a diet too high in calories.

20 Jun 2013

Ibrutinib shows remarkable promise for treatment of mantle cell lymphoma

In a major international study led by researchers at The University of Texas MD Anderson Cancer Center, the targeted therapy ibrutinib continues to show remarkable promise for the treatment of relapsed or refractory mantle cell lymphoma (MCL).

20 Jun 2013

Loyola researcher to study role of Vitamin D in women with diabetes and depression

A Loyola University Chicago Niehoff School of Nursing researcher has received a four-year, $1.49 million grant to study whether Vitamin D can improve mood in women with diabetes who are depressed.

20 Jun 2013

Insulin degludec has reduced risk of recurrent hypoglycemia than insulin glargine

Insulin degludec (Tresiba), a new ultra-long-acting insulin, has a similar or reduced risk of recurrent hypoglycemia—low blood sugar—compared with the commercially available insulin glargine, a new meta-analysis study finds.

19 Jun 2013

Scientists discover new drug that cripples TB bug by dissolving its protective fatty coating

Most humans would like to shed their fatty exteriors, but tuberculosis (TB)-causing bacteria rely on theirs for survival. Scientists at the University of Medicine and Dentistry of New Jersey (UMDNJ)-New Jersey Medical School have now discovered a drug that cripples the TB bug by dissolving its protective fatty coating, a finding that could eventually be used to improve TB treatment in humans. The study has been posted online by Nature Chemical Biology.

19 Jun 2013

Rice scientists apply drug-design lessons to production of industrial minerals

Taking a page from computer-aided drug designers, Rice University researchers have developed a computational method that chemists can use to tailor the properties of zeolites, one of the world's most-used industrial minerals.

19 Jun 2013

High Court: Feds can sue pharmaceutical companies over deals to delay generic drug sales

The Supreme Court ruled Monday that the Federal Trade Commission can challenge name brand drug makers for potential antitrust violations.

19 Jun 2013

Spinal infection at contaminated drug injection site detected using contrast-enhanced MRI screening

Magnetic resonance imaging (MRI) at the site of injection of a contaminated lot of a steroid drug to treat symptoms such as back pain resulted in earlier identification of patients with probable or confirmed fungal spinal or paraspinal infection, allowing early initiation of medical and surgical treatment, according to a study in the June 19 issue of JAMA.

19 Jun 2013

OHSU analysis finds previous studies have overstated effectiveness of bone growth product used in spinal surgeries

An analysis by the Evidence-based Practice Center at Oregon Health & Science University has found that previously published clinical trial studies about a controversial bone growth product used in spinal surgeries overstated the product's effectiveness.

19 Jun 2013

NIH awards $12.7M to research groups to explore new treatments for patients in eight disease areas

The National Institutes of Health has awarded $12.7 million to match nine academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for patients in eight disease areas, including Alzheimer's disease, Duchenne muscular dystrophy and schizophrenia.

19 Jun 2013

MMR booster does not result in worse JIA disease activity in children

Among children with juvenile idiopathic arthritis who had undergone primary immunization, the use of a measles-mumps-rubella booster compared with no booster did not result in worse JIA disease activity, according to a study in the June 19 issue of JAMA.

19 Jun 2013

Research shows that iodized salt used in bread not enough for pregnant women

Research from the University of Adelaide shows that iodized salt used in bread is not enough to provide healthy levels of iodine for pregnant women and their unborn children.

19 Jun 2013

Aspirin slows accumulation of DNA mutations in abnormal cells, points UCSF scientist

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells in at least one pre-cancerous condition.

19 Jun 2013

Eylea can ease vision problems for wet AMD patients

There is no cure for age-related macular degeneration, an eye disease that is the leading cause of vision loss and blindness in older Americans. Last year, the National Institutes of Health reported that two drugs injected into the eyes, Avastin and Lucentis, eased symptoms for sufferers, especially those in the advanced, "wet" stage of the disease, when blood vessels in the eye become swollen and leak fluids in the eye.

19 Jun 2013

Pharmaceutical News

FDA accepts DURECT's New Drug Application for POSIDUR

Report: Improper prescription drug use drives up cost of care

New study shows that dietary fructose causes liver damage even without weight gain

Ibrutinib shows remarkable promise for treatment of mantle cell lymphoma

Loyola researcher to study role of Vitamin D in women with diabetes and depression

Insulin degludec has reduced risk of recurrent hypoglycemia than insulin glargine

Scientists discover new drug that cripples TB bug by dissolving its protective fatty coating

Rice scientists apply drug-design lessons to production of industrial minerals

High Court: Feds can sue pharmaceutical companies over deals to delay generic drug sales

Spinal infection at contaminated drug injection site detected using contrast-enhanced MRI screening

OHSU analysis finds previous studies have overstated effectiveness of bone growth product used in spinal surgeries

NIH awards $12.7M to research groups to explore new treatments for patients in eight disease areas

MMR booster does not result in worse JIA disease activity in children

Research shows that iodized salt used in bread not enough for pregnant women

Aspirin slows accumulation of DNA mutations in abnormal cells, points UCSF scientist

Eylea can ease vision problems for wet AMD patients

Study: Timing of calcium, vitamin D supplementation affects skeletal adaptations to exercise training

First Edition: June 18, 2013

Antibiotic with clinical potential can stimulate own production, say scientists

Missing brain enzyme increases concentrations of protein related to pain-killer addiction

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News